Union Health Secy Visits Pharmaceutical Bilthoven Biologicals, Netherlands

Share on:

Health Secretary Apurva Chandra visited the manufacturing unit of global pharmaceutical company Bilthoven Biologicals at Utrecht in the Netherlands today. The Health Ministry said in a release that he had an engaging meeting with CEO Juergen Kwik and CEO of Poonawalla Science Park at Bilthoven, Jef De Clercq on EU pandemic preparedness partnership and collaboration on the production of vaccines. He met the senior management and was briefed on the various manufacturing units of the facility.

The bioengineering and vaccine production firm Bilthoven Biologicals was purchased by Serum India Ltd, in 2012. This has strengthened its capacity to produce vaccines and provided Serum India Ltd, with a valuable manufacturing base in Europe. 

Disclaimer: This press release is sourced from News On AIR, Prasar Bharti and Press Information Bureau India (PIB).

Rajendra Sen

Rajendra Sen is passionate about uncovering the stories that matter. As an award-winning journalist, defense expert, and dedicated social worker, he brings a compassionate and informed voice to his work.